Literature DB >> 21970826

Hyperimmunoglobulin E syndromes in pediatrics.

Qian Zhang1, Helen C Su.   

Abstract

PURPOSE OF REVIEW: The hyper-IgE syndromes (HIES) are primary immunodeficiencies characterized by eczema, sinopulmonary infections, and elevated serum IgE. This review discusses the clinical similarities and differences between the autosomal dominant HIES (AD-HIES) and autosomal recessive HIES (AR-HIES) forms, as well as their causative genetic and pathophysiological mechanisms. RECENT
FINDINGS: Over the past 4 years, three genetic defects have been identified in HIES. Mutations in STAT3 are associated with AD-HIES, whereas mutations in DOCK8, or rarely TYK2, are associated with AR-HIES. Recent work has confirmed that measuring T helper 17 cell numbers can help predict STAT3 mutations. In AR-HIES, loss of DOCK8 expression was found to impair T cell expansion and durable-specific antibody production by B cells. These factors probably contribute to the viral skin and other infectious susceptibilities, severe allergies, and high risk of malignancies that define this disorder.
SUMMARY: Establishing the molecular diagnosis of HIES is important for optimal patient management. Infections in AD-HIES are usually well controlled by antibiotics. By contrast, the viral infections in AR-HIES are difficult to manage. Their higher mortality and progressive course emphasizes the need to identify AR-HIES patients early, for consideration of potentially curative hematopoietic cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21970826      PMCID: PMC3294453          DOI: 10.1097/MOP.0b013e32834c7f65

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  40 in total

1.  Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.

Authors:  Evgenios Goussetis; Ioulia Peristeri; Vasiliki Kitra; Joanne Traeger-Synodinos; Maria Theodosaki; Katerina Psarra; Maria Kanariou; Fotini Tzortzatou-Stathopoulou; Eftichia Petrakou; Irene Fylaktou; Emmanuel Kanavakis; Stelios Graphakos
Journal:  J Allergy Clin Immunol       Date:  2010-07-02       Impact factor: 10.793

2.  Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.

Authors:  Lena F Schimke; Julie Sawalle-Belohradsky; Joachim Roesler; Andreas Wollenberg; Anita Rack; Michael Borte; Nikolaus Rieber; Reinhold Cremer; Eberhart Maass; Roland Dopfer; Janine Reichenbach; Volker Wahn; Manfred Hoenig; Annette F Jansson; Angela Roesen-Wolff; Bianca Schaub; Reinhard Seger; Harry R Hill; Hans D Ochs; Troy R Torgerson; Bernd H Belohradsky; Ellen D Renner
Journal:  J Allergy Clin Immunol       Date:  2010-09       Impact factor: 10.793

Review 3.  Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.

Authors:  Kerstin Felgentreff; Ruy Perez-Becker; Carsten Speckmann; Klaus Schwarz; Krzysztof Kalwak; Gasper Markelj; Tadej Avcin; Waseem Qasim; E G Davies; Tim Niehues; Stephan Ehl
Journal:  Clin Immunol       Date:  2011-05-30       Impact factor: 3.969

4.  Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations.

Authors:  Leena Chularojanamontri; Saranjit Wimoolchart; Papapit Tuchinda; Kanokvalai Kulthanan; Nisa Kiewjoy
Journal:  Asian Pac J Allergy Immunol       Date:  2009-12       Impact factor: 2.310

5.  Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patients.

Authors:  Roni Mintz; Ben Zion Garty; Tsipi Meshel; Nufar Marcus; Christina Katanov; Efrat Cohen-Hillel; Adit Ben-Baruch
Journal:  Immunol Lett       Date:  2009-12-11       Impact factor: 3.685

6.  Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.

Authors:  Karin R Engelhardt; Sean McGhee; Sabine Winkler; Atfa Sassi; Cristina Woellner; Gabriela Lopez-Herrera; Andrew Chen; Hong Sook Kim; Maria Garcia Lloret; Ilka Schulze; Stephan Ehl; Jens Thiel; Dietmar Pfeifer; Hendrik Veelken; Tim Niehues; Kathrin Siepermann; Sebastian Weinspach; Ismail Reisli; Sevgi Keles; Ferah Genel; Necil Kutukculer; Necil Kutuculer; Yildiz Camcioğlu; Ayper Somer; Elif Karakoc-Aydiner; Isil Barlan; Andrew Gennery; Ayse Metin; Aydan Degerliyurt; Maria C Pietrogrande; Mehdi Yeganeh; Zeina Baz; Salem Al-Tamemi; Christoph Klein; Jennifer M Puck; Steven M Holland; Edward R B McCabe; Bodo Grimbacher; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

7.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

8.  Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.

Authors:  Shadi Al Khatib; Sevgi Keles; Maria Garcia-Lloret; Elif Karakoc-Aydiner; Ismail Reisli; Hasibe Artac; Yildiz Camcioglu; Haluk Cokugras; Ayper Somer; Necil Kutukculer; Mustafa Yilmaz; Aydan Ikinciogullari; Olcay Yegin; Mutlu Yüksek; Ferah Genel; Ercan Kucukosmanoglu; Ali Baki; Nerin N Bahceciler; Anupama Rambhatla; Derek W Nickerson; Sean McGhee; Isil B Barlan; Talal Chatila
Journal:  J Allergy Clin Immunol       Date:  2009-07-03       Impact factor: 10.793

9.  Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Authors:  Cristina Woellner; E Michael Gertz; Alejandro A Schäffer; Macarena Lagos; Mario Perro; Erik-Oliver Glocker; Maria C Pietrogrande; Fausto Cossu; José L Franco; Nuria Matamoros; Barbara Pietrucha; Edyta Heropolitańska-Pliszka; Mehdi Yeganeh; Mostafa Moin; Teresa Español; Stephan Ehl; Andrew R Gennery; Mario Abinun; Anna Breborowicz; Tim Niehues; Sara Sebnem Kilic; Anne Junker; Stuart E Turvey; Alessandro Plebani; Berta Sánchez; Ben-Zion Garty; Claudio Pignata; Caterina Cancrini; Jiri Litzman; Ozden Sanal; Ulrich Baumann; Rosa Bacchetta; Amy P Hsu; Joie N Davis; Lennart Hammarström; E Graham Davies; Efrem Eren; Peter D Arkwright; Jukka S Moilanen; Dorothee Viemann; Sujoy Khan; László Maródi; Andrew J Cant; Alexandra F Freeman; Jennifer M Puck; Steven M Holland; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

10.  Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production.

Authors:  Katrina L Randall; Teresa Lambe; Andy L Johnson; Andy Johnson; Bebhinn Treanor; Edyta Kucharska; Heather Domaschenz; Belinda Whittle; Lina E Tze; Anselm Enders; Tanya L Crockford; Tiphaine Bouriez-Jones; Duncan Alston; Jason G Cyster; Michael J Lenardo; Fabienne Mackay; Elissa K Deenick; Stuart G Tangye; Tyani D Chan; Tahra Camidge; Robert Brink; Carola G Vinuesa; Facundo D Batista; Richard J Cornall; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

View more
  11 in total

Review 1.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

2.  Additional diverse findings expand the clinical presentation of DOCK8 deficiency.

Authors:  Ozden Sanal; Huie Jing; Tuba Ozgur; Deniz Ayvaz; Dara M Strauss-Albee; Sibel Ersoy-Evans; Ilhan Tezcan; Gulten Turkkani; Helen F Matthews; Goknur Haliloglu; Aysel Yuce; Bilgehan Yalcin; Ozay Gokoz; Kader K Oguz; Helen C Su
Journal:  J Clin Immunol       Date:  2012-04-04       Impact factor: 8.317

3.  Progressive multifocal leukoencephalopathy in a patient with lymphoma and presumptive hyper IgE syndrome.

Authors:  Rahsan Gocmen; Nazire Pinar Acar; Deniz Cagdas; Asli Kurne
Journal:  J Neurovirol       Date:  2017-06-22       Impact factor: 2.643

4.  Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.

Authors:  Melissa C Mizesko; Pinaki P Banerjee; Linda Monaco-Shawver; Emily M Mace; William E Bernal; Julie Sawalle-Belohradsky; Bernd H Belohradsky; Valerie Heinz; Alexandra F Freeman; Kathleen E Sullivan; Steven M Holland; Troy R Torgerson; Waleed Al-Herz; Janet Chou; Imelda C Hanson; Michael H Albert; Raif S Geha; Ellen D Renner; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

5.  Neurobehavioral profiles in individuals with hyperimmunoglobulin E Syndrome (HIES) and brain white matter hyperintensities.

Authors:  Staci Martin; Pamela Wolters; Nia Billings; Mary Anne Toledo-Tamula; Dima A Hammoud; Pamela Welch; Dirk Darnell; Steven M Holland; Alexandra F Freeman
Journal:  J Clin Immunol       Date:  2013-08-21       Impact factor: 8.317

Review 6.  Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.

Authors:  Anna B Fishbein; Jonathan I Silverberg; Eve J Wilson; Peck Y Ong
Journal:  J Allergy Clin Immunol Pract       Date:  2019-08-29

7.  Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 Mutation.

Authors:  Chad J Cooper; Sarmad Said; German T Hernandez
Journal:  Case Reports Immunol       Date:  2014-03-05

Review 8.  New genetic discoveries and primary immune deficiencies.

Authors:  Vivian Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 10.817

Review 9.  The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis.

Authors:  Lei Bao; Huayi Zhang; Lawrence S Chan
Journal:  JAKSTAT       Date:  2013-08-15

10.  Metabolomics Distinguishes DOCK8 Deficiency from Atopic Dermatitis: Towards a Biomarker Discovery.

Authors:  Minnie Jacob; Xinyun Gu; Xian Luo; Hamoud Al-Mousa; Rand Arnaout; Bandar Al-Saud; Andreas L Lopata; Liang Li; Majed Dasouki; Anas M Abdel Rahman
Journal:  Metabolites       Date:  2019-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.